Literature DB >> 2459293

Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques.

A B Gottlieb1, A D Luster, D N Posnett, D M Carter.   

Abstract

The pathologic features of psoriatic plaques are inflammation and increased epidermal turnover. IP-10, a cytokine the expression of which is induced by gamma-interferon, is a member of a family of soluble mediators with inflammatory and growth-promoting activities. IP-10 protein was detected in keratinocytes and the dermal infiltrate from active psoriatic plaques using an affinity-purified rabbit anti-IP-10 antibody in immunoperoxidase studies. Successful treatment of active plaques decreased IP-10 expression in plaques. These results were corroborated by Northern blot analysis with an IP-10 cDNA probe. We have previously detected activated T cells and HLA-DR keratinocytes in active psoriatic plaques. Since IP-10 is detected in delayed cellular immune responses, the present study further points to the role of ongoing cellular immune responses in the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459293      PMCID: PMC2189020          DOI: 10.1084/jem.168.3.941

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

Review 1.  Immunologic mechanisms in psoriasis.

Authors:  A B Gottlieb
Journal:  J Am Acad Dermatol       Date:  1988-06       Impact factor: 11.527

2.  Clonal growth of human keratinocytes with small amounts of dialyzed serum.

Authors:  D M Peehl; R G Ham
Journal:  In Vitro       Date:  1980-06

3.  Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes.

Authors:  T Y Basham; B J Nickoloff; T C Merigan; V B Morhenn
Journal:  J Invest Dermatol       Date:  1984-08       Impact factor: 8.551

4.  The use of monoclonal antibody to keratin in human epidermal disease: alterations in immunohistochemical staining pattern.

Authors:  R A Weiss; G Y Guillet; I M Freedberg; E R Farmer; E A Small; M M Weiss; T T Sun
Journal:  J Invest Dermatol       Date:  1983-09       Impact factor: 8.551

5.  Epidermal T lymphocytes and HLA-DR expression in psoriasis.

Authors:  B S Baker; A F Swain; L Fry; H Valdimarsson
Journal:  Br J Dermatol       Date:  1984-05       Impact factor: 9.302

6.  Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF).

Authors:  T A Luger; B M Stadler; S I Katz; J J Oppenheim
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

7.  Lectins as markers of human epidermal cell differentiation.

Authors:  A Reano; M Faure; Y Jacques; U Reichert; H Schaefer; J Thivolet
Journal:  Differentiation       Date:  1982       Impact factor: 3.880

8.  Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed.

Authors:  P Gunning; P Ponte; H Okayama; J Engel; H Blau; L Kedes
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.

Authors:  C Heufler; F Koch; G Schuler
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  42 in total

Review 1.  Immunological mechanisms involved in psoriasis.

Authors:  C E Griffiths; J J Voorhees
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Adhesion molecules and IL-1 costimulate T lymphocytes in the autologous MECLR in psoriasis.

Authors:  E Prens; K t Hooft-Benne; B Tank; J Van Damme; T van Joost; R Benner
Journal:  Arch Dermatol Res       Date:  1996-02       Impact factor: 3.017

3.  Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.

Authors:  Z Bata-Csorgo; C Hammerberg; J J Voorhees; K D Cooper
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

Review 4.  CXCR3 ligands: redundant, collaborative and antagonistic functions.

Authors:  Joanna R Groom; Andrew D Luster
Journal:  Immunol Cell Biol       Date:  2011-01-11       Impact factor: 5.126

5.  Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases.

Authors:  Clara Lubeseder-Martellato; Eric Guenzi; Anita Jörg; Kristin Töpolt; Elisabeth Naschberger; Elisabeth Kremmer; Christian Zietz; Erwin Tschachler; Peter Hutzler; Martin Schwemmle; Kathrin Matzen; Thomas Grimm; Barbara Ensoli; Michael Stürzl
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

6.  Changes of serum cytokine profiles in Korean vivax malarial patients after chemotherapy.

Authors:  T S Kim; Y B Chung; H J Choi; H J Yang
Journal:  Parasitol Res       Date:  2006-07-11       Impact factor: 2.289

7.  Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy.

Authors:  Francesca Gotsch; Roberto Romero; Jimmy Espinoza; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Offer Erez; Nandor Gabor Than; Samuel Edwin; Moshe Mazor; Bo Hyan Yoon; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-10

8.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Authors:  Hak-Ling Ma; Spencer Liang; Jing Li; Lee Napierata; Tom Brown; Stephen Benoit; Mayra Senices; Davinder Gill; Kyriaki Dunussi-Joannopoulos; Mary Collins; Cheryl Nickerson-Nutter; Lynette A Fouser; Deborah A Young
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

9.  Interleukin-1 receptor antagonist in normal and psoriatic epidermis.

Authors:  C Hammerberg; W P Arend; G J Fisher; L S Chan; A E Berger; J S Haskill; J J Voorhees; K D Cooper
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

10.  Increased expression of interleukin-4 receptors on psoriatic epidermal cells.

Authors:  E Prens; J Hegmans; R C Lien; R Debets; R Troost; T van Joost; R Benner
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.